WuXi AppTec (WX8) Stock Overview
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
WX8 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
WuXi AppTec Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.75 |
| 52 Week High | CN¥14.33 |
| 52 Week Low | CN¥6.65 |
| Beta | 0.54 |
| 1 Month Change | 10.00% |
| 3 Month Change | 12.70% |
| 1 Year Change | 106.77% |
| 3 Year Change | 77.42% |
| 5 Year Change | -6.78% |
| Change since IPO | 323.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| WX8 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 4.7% | -10.5% | -1.8% |
| 1Y | 106.8% | -18.4% | 2.6% |
Return vs Industry: WX8 exceeded the German Life Sciences industry which returned -15.3% over the past year.
Return vs Market: WX8 exceeded the German Market which returned 3.5% over the past year.
Price Volatility
| WX8 volatility | |
|---|---|
| WX8 Average Weekly Movement | 6.1% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: WX8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: WX8's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 33,834 | Ge Li | www.wuxiapptec.com |
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.
WuXi AppTec Co., Ltd. Fundamentals Summary
| WX8 fundamental statistics | |
|---|---|
| Market cap | €42.12b |
| Earnings (TTM) | €2.35b |
| Revenue (TTM) | €5.77b |
Is WX8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WX8 income statement (TTM) | |
|---|---|
| Revenue | CN¥46.20b |
| Cost of Revenue | CN¥22.78b |
| Gross Profit | CN¥23.42b |
| Other Expenses | CN¥4.62b |
| Earnings | CN¥18.80b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.30 |
| Gross Margin | 50.70% |
| Net Profit Margin | 40.69% |
| Debt/Equity Ratio | 9.4% |
How did WX8 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/29 13:10 |
| End of Day Share Price | 2026/04/27 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
WuXi AppTec Co., Ltd. is covered by 45 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Zhishun Siu | CCB International Securities Limited |
| Pei Cheng | China Galaxy Securities Co., Ltd. |